Shares Of A Biotech Company That DIDN'T Make The Drug That Saved The Ebola-Infected Doctor Are Surging
Advertisement
REUTERS/Frederick Murphy/CDC/Handout
Advertisement
ZMapp was developed by Mapp Biopharmaceutical, a privately held company.
It's not to be confused with MAP Pharmceuticals, which was acquired by Allergan in 2013.
Tekmira Pharmaceuticals, which also has an experimental ebola drug in the works, is up by around 5% in pre-market trading. It's unclear why.
Here's the after-hours and pre-market moves in Tekmira according to MarketWatch.
Advertisement
Advertisement
- A centenarian who starts her day with gentle exercise and loves walks shares 5 longevity tips, including staying single
- A couple accidentally shipped their cat in an Amazon return package. It arrived safely 6 days later, hundreds of miles away.
- Colon cancer rates are rising in young people. If you have two symptoms you should get a colonoscopy, a GI oncologist says.
- Having an regional accent can be bad for your interviews, especially an Indian one: study
- Dirty laundry? Major clothing companies like Zara and H&M under scrutiny for allegedly fuelling deforestation in Brazil
- 5 Best places to visit near Darjeeling
- Climate change could become main driver of biodiversity decline by mid-century: Study
- RBI initiates transition plan: Small finance banks to ascend to universal banking status